Seminars in Immunology

Papers
(The median citation count of Seminars in Immunology is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Editorial Board374
Differential immune responses behind different celiac disease manifestations106
Three’s company: The cooperative signals behind the differentiation of Th9 cells96
COVID-19 in Latin America: Clinical and immunological insights, vaccine development, and lessons for pandemic preparedness92
Exploiting antifungal immunity in the clinical context88
Cellular stress and macrophage activation85
Accumulation of immune-suppressive CD4 + T cells in aging – tempering inflammaging at the expense of immunity83
Myeloid derived suppressor cells in tumor microenvironment: Interaction with innate lymphoid cells83
Editorial Board73
Oncolytic virus-mediated immunomodulation in glioblastoma: Insights from clinical trials and challenges69
They shall not grow mold: Soldiers of innate and adaptive immunity to fungi68
Microbial metabolites and immunotherapy: Basic rationale and clinical indications64
NGS data analysis for molecular diagnosis of Inborn Errors of Immunity62
Local and Cell-intrinsic complement: The new player in cancer progression59
Pyroptosis modulation by bacterial effector proteins56
Aging of lymphoid stromal architecture impacts immune responses56
Immunoglobulins at the interface of the gut mycobiota and anti-fungal immunity50
Immunity to pathogenic fungi in the eye50
IL-1 family members as regulators of lymphoid type-2 immunity in cancer48
Therapeutic immune tolerance for central nervous system autoimmune diseases – Prospects, challenges and pitfalls45
Different routes of MHC-I delivery to phagosomes and their consequences to CD8 T cell immunity43
Seminars in immunology special issue: Nutrition, microbiota and immunity The unexplored microbes in health and disease42
Pyroptosis: A road to next-generation cancer immunotherapy42
Pyroptosis and the cellular consequences of gasdermin pores41
The noncanonical inflammasome-induced pyroptosis and septic shock40
Western diet influences on microbiome and carcinogenesis39
Beyond the Norm: The emerging interplay of complement system and extracellular matrix in the tumor microenvironment39
Interplay between the complement system and other immune pathways in the tumor microenvironment38
The paradox of aging: Aging-related shifts in T cell function and metabolism35
Immunity to fungi: Editorial overview35
Autoimmune diabetes and targets for immunomodulation34
Neuroimmune interactions between itch neurons and skin microbes34
Interleukin-1β and cancer immune response34
TREM2: A new player in the tumor microenvironment33
Adaptive NK cell response to human cytomegalovirus: Facts and open issues33
Resolution pharmacology − A fresh approach to the clinical management of human inflammatory diseases32
The evolving biology of cross-presentation32
Sialic acid and Siglec receptors in tumor immunity and immunotherapy31
Annexin A1 based inflammation resolving mediators and nanomedicines for inflammatory bowel disease therapy31
Antigen discovery for the development of cancer immunotherapy31
Diverse IL-9-secreting T helper cells direct responses in the allergic lung29
Thymus aging and immune reconstitution, progresses and challenges29
The multifaceted role of B lymphocytes in type 1 diabetes29
The immunological processes behind aquaporin 4-antibody seropositive neuromyelitis optica spectrum disorders28
The tissue glycome as regulator of immune activation and tolerance mediated by C-type lectins and Siglecs28
Individual- and population-associated heterogeneity in vaccine-induced immune responses. The impact of inflammatory status and diabetic comorbidity28
T cell control of SARS-CoV-2: When, which, and where?28
Age-dependent changes in T follicular helper cells shape the humoral immune response to vaccination28
Introduction to the Special Issue: Nutrition, microbiota and immunity28
T cell fate decisions during memory cell generation with aging27
Activation of B cells in Tertiary Lymphoid Structures in cancer: Anti-tumor or anti-self?27
Antigen cross-presentation by dendritic cells: A critical axis in cancer immunotherapy27
What fungal CNS infections can teach us about neuroimmunology and CNS-specific immunity27
Epithelial inflammasomes, gasdermins, and mucosal inflammation – Lessons from Salmonella and Shigella infected mice26
Immunotherapy targeting inhibitory checkpoints: The role of NK and other innate lymphoid cells26
Editorial Board26
Regulation of innate immune system function by the microbiome: Consequences for tumor immunity and cancer immunotherapy25
Proteostasis in T cell aging24
Human thymus in health and disease: Recent advances in diagnosis and biology24
Better safe than sorry: Naive T-cell dynamics in healthy ageing24
The complement system in clinical oncology: Applications, limitations and challenges24
The glycoimmune landscape in health and disease24
A major mechanism for immunomodulation: Dietary fibres and acid metabolites23
Global aspects of celiac disease and food allergy23
New insights into Th9 cells in inflammatory bowel diseases21
Harnessing complement biomarkers for precision cancer care20
To kill or not to kill – The role of the tumor microenvironment in shaping group 1 ILC functions19
Epigenetic and transcriptional control of gasdermins19
The multisensory regulation of unconventional T cell homeostasis19
Disorganization of secondary lymphoid organs and dyscoordination of chemokine secretion as key contributors to immune aging19
Complement regulators as novel targets for anti-cancer therapy: A comprehensive review19
The role of non-cancer cell infections in oncolytic virus therapy19
Siglecs as modulators of macrophage phenotype and function18
Unraveling the pathophysiology of narcolepsy type 1 through hypothesis-driven and hypothesis-generating approaches18
Tumor associated macrophage in HPV+ tumors: Between immunosuppression and inflammation18
Editorial Board18
Unconventional protein secretion by gasdermin pores18
Editorial: Autoimmune diseases of the central nervous system18
Microbial gasdermins: More than a billion years of pyroptotic-like cell death17
Development of synthetic lipoxin-A4 mimetics (sLXms): New avenues in the treatment of cardio-metabolic diseases17
Systems analysis of innate and adaptive immunity in Long COVID17
T follicular helper cells in cancer, tertiary lymphoid structures, and beyond17
The role of ILC subsets in cancer17
Pyroptosis-induced inflammation and tissue damage17
Durability of immune responses to SARS-CoV-2 infection and vaccination17
IL-1R8: A molecular brake of anti-tumor and anti-viral activity of NK cells and ILC17
Macronutrient availability and immune cell responses17
Complement regulation in tumor immune evasion16
Impact of dietary carbohydrate restriction on the pathobiology of Hepatocellular Carcinoma: The gut-liver axis and beyond16
Introduction to the Special Issue: Pyroptosis in Immunity and Inflammation16
Integrating immunopeptidome analysis for the design and development of cancer vaccines16
Galectins and Host–Pathogen Interactions: The roles in viral infections16
Editorial Board16
Variable domain glycosylation as a marker and modulator of immune responses: Insights into autoimmunity and B-cell malignancies16
The gut-brain vascular axis in neuroinflammation15
Numbers and odds: TCR repertoire size and its age changes impacting on T cell functions15
Endogenous glucocorticoids and human immunity: Time to revisit old dogmas15
The spatial and single-cell landscape of skin: Charting the multiscale regulation of skin immune function14
Somatic mosaicism in inborn errors of immunity: Current knowledge, challenges, and future perspectives14
Systems analysis of human innate immunity in COVID-1914
Chemical modulation of gasdermin D activity: Therapeutic implications and consequences14
Regulatory T cells in allergic inflammation14
To die or not to die: Gasdermins in intestinal health and disease13
Immunity to fungi in the lung13
Inflammation-mediated tissue damage in pulmonary tuberculosis and host-directed therapeutic strategies13
Editorial Board13
The role of sialoglycans in modulating dendritic cell function and tumour immunity12
Chronic Chagas disease and type 2 diabetes comorbidity. The scenario in which two differently driven inflammatory mechanisms meet12
Uncovered role of Th9 and IL-9 in rheumatoid arthritis: Current status and future directions12
Beyond youth: Understanding CAR T cell fitness in the context of immunological aging11
Editorial Board11
Aging unconventionally: γδ T cells, iNKT cells, and MAIT cells in aging11
The origins, manifestations, and potential treatments of allergic disorders11
Latest insights into oncolytic viro-immunotherapy with vesicular stomatitis virus11
Access to CAR-T therapy in Latin America: Barriers, gaps, and pathways forward11
0.15846109390259